Citations (3)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Teppei Hagino, Risa Hamada, Mai Yoshida, Eita Fujimoto, Hidehisa Saeki & Naoko Kanda. (2023) Effectiveness and Safety of Upadacitinib in Combination with Topical Corticosteroids in Adolescent Patients with Moderate-to-Severe Atopic Dermatitis. Clinical, Cosmetic and Investigational Dermatology 16, pages 3201-3212.
Read now
Read now
Teppei Hagino, Mai Yoshida, Risa Hamada, Hidehisa Saeki, Eita Fujimoto & Naoko Kanda. (2023) Effectiveness of switching from baricitinib 4 mg to upadacitinib 30 mg in patients with moderate-to-severe atopic dermatitis: a real-world clinical practice in Japan. Journal of Dermatological Treatment 34:1.
Read now
Read now
Articles from other publishers (1)
Teppei Hagino, Mai Yoshida, Risa Hamada, Eita Fujimoto, Hidehisa Saeki & Naoko Kanda. (2023)
Therapeutic effectiveness of upadacitinib on individual types of rash in Japanese patients with
moderate‐to‐severe
atopic dermatitis
. The Journal of Dermatology 50:12, pages 1576-1584.
Crossref
Crossref